173 related articles for article (PubMed ID: 35729639)
1. Comprehensive analysis of microglia gene and subpathway signatures for glioma prognosis and drug screening: linking microglia to glioma.
Zhang C; Zhao J; Mi W; Zhang Y; Zhong X; Tan G; Li F; Li X; Xu Y; Zhang Y
J Transl Med; 2022 Jun; 20(1):277. PubMed ID: 35729639
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Features of the Tumor Immune Microenvironment in Glioma and Their Clinical Applications: Analysis of Multiple Cohorts.
Zhang C; Zhang Y; Tan G; Mi W; Zhong X; Zhang Y; Zhao Z; Li F; Xu Y; Zhang Y
Front Immunol; 2022; 13():853074. PubMed ID: 35677045
[TBL] [Abstract][Full Text] [Related]
3. Glioma-associated microglia/macrophages display an expression profile different from M1 and M2 polarization and highly express Gpnmb and Spp1.
Szulzewsky F; Pelz A; Feng X; Synowitz M; Markovic D; Langmann T; Holtman IR; Wang X; Eggen BJ; Boddeke HW; Hambardzumyan D; Wolf SA; Kettenmann H
PLoS One; 2015; 10(2):e0116644. PubMed ID: 25658639
[TBL] [Abstract][Full Text] [Related]
4. Distribution and prognostic impact of microglia/macrophage subpopulations in gliomas.
Zeiner PS; Preusse C; Golebiewska A; Zinke J; Iriondo A; Muller A; Kaoma T; Filipski K; Müller-Eschner M; Bernatz S; Blank AE; Baumgarten P; Ilina E; Grote A; Hansmann ML; Verhoff MA; Franz K; Feuerhake F; Steinbach JP; Wischhusen J; Stenzel W; Niclou SP; Harter PN; Mittelbronn M
Brain Pathol; 2019 Jul; 29(4):513-529. PubMed ID: 30506802
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive gene expression meta-analysis identifies signature genes that distinguish microglia from peripheral monocytes/macrophages in health and glioma.
Haage V; Semtner M; Vidal RO; Hernandez DP; Pong WW; Chen Z; Hambardzumyan D; Magrini V; Ly A; Walker J; Mardis E; Mertins P; Sauer S; Kettenmann H; Gutmann DH
Acta Neuropathol Commun; 2019 Feb; 7(1):20. PubMed ID: 30764877
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Gene Expression Signature in Patients With Distinct Glioma Grades.
Ait Ssi S; Chraa D; El Azhary K; Sahraoui S; Olive D; Badou A
Front Immunol; 2021; 12():685213. PubMed ID: 34539626
[TBL] [Abstract][Full Text] [Related]
7. Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response.
Sielska M; Przanowski P; Wylot B; Gabrusiewicz K; Maleszewska M; Kijewska M; Zawadzka M; Kucharska J; Vinnakota K; Kettenmann H; Kotulska K; Grajkowska W; Kaminska B
J Pathol; 2013 Jul; 230(3):310-21. PubMed ID: 23520016
[TBL] [Abstract][Full Text] [Related]
8. F11R is a novel monocyte prognostic biomarker for malignant glioma.
Pong WW; Walker J; Wylie T; Magrini V; Luo J; Emnett RJ; Choi J; Cooper ML; Griffith M; Griffith OL; Rubin JB; Fuller GN; Piwnica-Worms D; Feng X; Hambardzumyan D; DiPersio JF; Mardis ER; Gutmann DH
PLoS One; 2013; 8(10):e77571. PubMed ID: 24147027
[TBL] [Abstract][Full Text] [Related]
9. Oligodendrocyte Progenitor Cells and Macrophages/Microglia Produce Glioma Stem Cell Niches at the Tumor Border.
Hide T; Komohara Y; Miyasato Y; Nakamura H; Makino K; Takeya M; Kuratsu JI; Mukasa A; Yano S
EBioMedicine; 2018 Apr; 30():94-104. PubMed ID: 29559295
[TBL] [Abstract][Full Text] [Related]
10. Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas.
Komohara Y; Ohnishi K; Kuratsu J; Takeya M
J Pathol; 2008 Sep; 216(1):15-24. PubMed ID: 18553315
[TBL] [Abstract][Full Text] [Related]
11. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
[TBL] [Abstract][Full Text] [Related]
12. Microglia-glioma cross-talk: a two way approach to new strategies against glioma.
Arcuri C; Fioretti B; Bianchi R; Mecca C; Tubaro C; Beccari T; Franciolini F; Giambanco I; Donato R
Front Biosci (Landmark Ed); 2017 Jan; 22(2):268-309. PubMed ID: 27814616
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of mRNA-level and miRNA-level subpathway activities for identifying robust ovarian cancer prognostic signatures.
Tian S; Mi W; Zhang M; Xing L; Zhang C
J Cell Mol Med; 2020 Feb; 24(4):2582-2592. PubMed ID: 31957240
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M
Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618
[TBL] [Abstract][Full Text] [Related]
15. Deletion of Neuropilin 1 from Microglia or Bone Marrow-Derived Macrophages Slows Glioma Progression.
Miyauchi JT; Caponegro MD; Chen D; Choi MK; Li M; Tsirka SE
Cancer Res; 2018 Feb; 78(3):685-694. PubMed ID: 29097606
[TBL] [Abstract][Full Text] [Related]
16. Molecular profiling of the tumor microenvironment in glioblastoma patients: correlation of microglia/macrophage polarization state with metalloprotease expression profiles and survival.
Gjorgjevski M; Hannen R; Carl B; Li Y; Landmann E; Buchholz M; Bartsch JW; Nimsky C
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31142630
[TBL] [Abstract][Full Text] [Related]
17. A nonmyeloablative chimeric mouse model accurately defines microglia and macrophage contribution in glioma.
Yu K; Youshani AS; Wilkinson FL; O'Leary C; Cook P; Laaniste L; Liao A; Mosses D; Waugh C; Shorrock H; Pathmanaban O; Macdonald A; Kamaly-Asl I; Roncaroli F; Bigger BW
Neuropathol Appl Neurobiol; 2019 Feb; 45(2):119-140. PubMed ID: 29679380
[TBL] [Abstract][Full Text] [Related]
18. Single-cell transcriptome-based multilayer network biomarker for predicting prognosis and therapeutic response of gliomas.
Zhang J; Guan M; Wang Q; Zhang J; Zhou T; Sun X
Brief Bioinform; 2020 May; 21(3):1080-1097. PubMed ID: 31329830
[TBL] [Abstract][Full Text] [Related]
19. Six Immune Associated Genes Construct Prognostic Model Evaluate Low-Grade Glioma.
Tan YQ; Li YT; Yan TF; Xu Y; Liu BH; Yang JA; Yang X; Chen QX; Zhang HB
Front Immunol; 2020; 11():606164. PubMed ID: 33408717
[TBL] [Abstract][Full Text] [Related]
20. Development of a nomogram for prognostic prediction of lower-grade glioma based on alternative splicing signatures.
Wang Y; Wang Z; Zhao B; Chen W; Wang Y; Ma W
Cancer Med; 2020 Dec; 9(24):9266-9281. PubMed ID: 33047900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
